featured
Effects of Dapagliflozin on Volume Status and Systemic Hemodynamics in Patients With Chronic Kidney Disease Without Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effects of dapagliflozin on volume status and systemic hemodynamics in patients with CKD without diabetes: Results from DAPASALT and DIAMOND
Diabetes Obes Metab 2022 Apr 28;[EPub Ahead of Print], T Sen, R Scholtes, PJ Greasley, D Cherney, CCJ Dekkers, M Vervloet, AHJ Danser, S Barbour, C Karlsson, A Hammarstedt, Q Li, GD Laverman, P Bjornstad, DH van Raalte, HJL HeerspinkFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.